Drug Development Must Be Patient-Centric; Adherence Schemes Must Follow
This article was originally published in The Pink Sheet Daily
Executive Summary
Global health systems are losing billions of dollars by not introducing schemes to tackle drug adherence, but are heading in the right direction with patient-centric drug development.